
Beam Therapeutics BEAM
$ 27.94
-4.61%
Quarterly report 2025-Q3
added 11-04-2025
Beam Therapeutics P/S Ratio 2011-2026 | BEAM
Annual P/S Ratio Beam Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.4 | 9.3 | 46.5 | 85.7 | 188 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 188 K | 9.3 | 37.6 K |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
35.6 | $ 2.75 | -5.5 % | $ 155 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 81.6 | -0.49 % | $ 1.58 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
4.68 | $ 342.65 | -0.08 % | $ 184 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.63 | 1.74 % | $ 16.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.17 | -2.76 % | $ 7.63 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Biogen
BIIB
|
2 | $ 178.24 | 1.2 % | $ 26 B | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 225.36 | 0.63 % | $ 5 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 114.18 | -2.22 % | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.67 | 0.16 % | $ 1.52 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 70.74 | 2.34 % | $ 9.46 B | ||
|
CASI Pharmaceuticals
CASI
|
36.1 | $ 0.99 | -0.01 % | $ 135 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 9.63 | -5.08 % | $ 634 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.05 | -1.22 % | $ 8.81 B | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 13.65 | -3.3 % | $ 4.22 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Cerus Corporation
CERS
|
1.49 | $ 2.32 | -0.22 % | $ 428 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K |